Article

MET-TKIs selectively inhibit growth of hepatobiliary carcinoma harboring high copy number MET amplification: 2 cases and literature review

2026-04-19

Abstract excerpt

<title>Abstract</title> <p>Objective To investigate the efficacy of highly selective MET-TKIs, targeting met exon14 skipping muation, in patients with hepatobiliary carcinoma harboring MET amplification. Methods Clinical data from two patients with advanced metastatic hepatobiliary carcinoma and MET gene amplification were collected. Literature review was conducted to analyze the clinical characteristics of the...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 24b76b05-06fd-53b0-bf11-f9d68de24e76
DOI: 10.21203/rs.3.rs-8898860/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

MET-TKIs selectively inhibit growth of hepatobiliary carcinoma harboring high copy number MET amplification: 2 cases and literature reviewDOI 10.21203/rs.3.rs-8898860/v1Read

MET-dependent solid tumours - molecular diagnosis and targeted therapy.Semantic proximity Read

MET-Targeted Therapies and Clinical Outcomes: A Systematic Literature Review.Semantic proximity Read

Targeting MET Dysregulation in CancerSemantic proximity Read

Gastric cancer patient with c-MET amplification treated with crizotinib after failed multi-line treatment: A case report and literature reviewSemantic proximity Read

Analysis of 1,115 patients tested for MET amplification and therapy response in the MD Anderson Phase I Clinic.Semantic proximity Read

Overcoming resistance to targeted therapy using MET inhibitors in solid cancers: evidence from preclinical and clinical studies.Semantic proximity Read

[Progress on Mechanism of MET Gene Mutation and Targeted Drugs in Non-small Cell Lung Cancer].Semantic proximity Read

Phase II, open-label, multicenter trial of crizotinib in Japanese patients with advanced non-small cell lung cancer harboring a MET gene alteration: Co-MET study.Semantic proximity Read

Targeting mesenchymal-epithelial transition factor signaling in cancer: from genetic alterations to clinical advances and future prospects.Semantic proximity Read

Optimal Treatments for NSCLC Patients Harboring Primary or Acquired MET Amplification.Semantic proximity Read

<i>MET</i> amplification as a potential therapeutic target in gastric cancerSemantic proximity Read

Advanced hepatocellular carcinoma with MET-amplified contained excellent response to Crizotinib: a case report.Semantic proximity Read